North Dakota § 43-17.1-02 Investigative panels of the board

North Dakota Statutes

§ 43-17.1-02 — Investigative panels of the board

North Dakota § 43-17.1-02

Title 43Occupations and Professions

Ch. 43-17.1Board of Medicine Investigative Panels

This text of North Dakota § 43-17.1-02 (Investigative panels of the board) is published on Counsel Stack Legal Research, covering North Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.D. Cent. Code § 43-17.1-02 (2026).

Text

1.For the purpose of investigating complaints or other information that might give rise to a disciplinary proceeding against a licensee, the executive director of the board shall designate two investigative panels, each composed of six members of the board. Five members of each panel must be physician members of the board. One member of each panel must be a public member of the board. One member of each panel must be a physician assistant.

2.Each investigative panel shall select a chairman and a vice chairman from its own members.

3.Each investigative panel may engage and share information with investigators, medical experts, and such other experts as the panel in its discretion determines to be necessary to accomplish its purposes. Information shared to such entities or individuals rem

Free access — add to your briefcase to read the full text and ask questions with AI

1. For the purpose of investigating complaints or other information that might give rise to
a disciplinary proceeding against a licensee, the executive director of the board shall
designate two investigative panels, each composed of six members of the board. Five
members of each panel must be physician members of the board. One member of
each panel must be a public member of the board. One member of each panel must
be a physician assistant.
2. Each investigative panel shall select a chairman and a vice chairman from its own
members.
3. Each investigative panel may engage and share information with investigators,
medical experts, and such other experts as the panel in its discretion determines to be
necessary to accomplish its purposes. Information shared to such entities or
individuals remains confidential in the possession of the entities.
4. Cases for investigation must be assigned to each investigative panel by the executive
director of the board.